Literature DB >> 8024571

Concanamycin A: a powerful inhibitor of enveloped animal-virus entry into cells.

R Guinea1, L Carrasco.   

Abstract

Concanamycin A, a selective inhibitor of the vacuolar proton ATPase, blocks the infection of animal cells by vesicular stomatitis virus, Semliki Forest virus and influenza virus even when the drug is present at the low concentration of 5 nM. Nevertheless the antibiotic prevents neither the attachment, to cells, of Semliki Forest virus nor its subsequent internalization. Under certain conditions, described in this communication, virus entry is prevented even when the pH of the medium is low, thus suggesting that a pH gradient, rather than low pH per se, is required to drive the entry, into cells, of these enveloped animal viruses.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8024571     DOI: 10.1006/bbrc.1994.1842

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

1.  The entry of reovirus into L cells is dependent on vacuolar proton-ATPase activity.

Authors:  C G Martínez; R Guinea; J Benavente; L Carrasco
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

2.  Crystal structure of the yeast vacuolar ATPase heterotrimeric EGC(head) peripheral stalk complex.

Authors:  Rebecca A Oot; Li-Shar Huang; Edward A Berry; Stephan Wilkens
Journal:  Structure       Date:  2012-09-20       Impact factor: 5.006

3.  Requirement for vacuolar proton-ATPase activity during entry of influenza virus into cells.

Authors:  R Guinea; L Carrasco
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

4.  Dengue-3 Virus Entry into Vero Cells: Role of Clathrin-Mediated Endocytosis in the Outcome of Infection.

Authors:  Luana E Piccini; Viviana Castilla; Elsa B Damonte
Journal:  PLoS One       Date:  2015-10-15       Impact factor: 3.240

Review 5.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-12

Review 6.  Progress of small molecular inhibitors in the development of anti-influenza virus agents.

Authors:  Xiaoai Wu; Xiuli Wu; Qizheng Sun; Chunhui Zhang; Shengyong Yang; Lin Li; Zhiyun Jia
Journal:  Theranostics       Date:  2017-02-08       Impact factor: 11.556

7.  Targeting of arenavirus RNA synthesis by a carboxamide-derivatized aromatic disulfide with virucidal activity.

Authors:  Claudia S Sepúlveda; Cybele C García; Jesica M Levingston Macleod; Nora López; Elsa B Damonte
Journal:  PLoS One       Date:  2013-11-20       Impact factor: 3.240

Review 8.  Structural differences observed in arboviruses of the alphavirus and flavivirus genera.

Authors:  Raquel Hernandez; Dennis T Brown; Angel Paredes
Journal:  Adv Virol       Date:  2014-09-16

Review 9.  Modification of membrane permeability by animal viruses.

Authors:  L Carrasco
Journal:  Adv Virus Res       Date:  1995       Impact factor: 9.937

10.  Alternative infectious entry pathways for dengue virus serotypes into mammalian cells.

Authors:  Eliana G Acosta; Viviana Castilla; Elsa B Damonte
Journal:  Cell Microbiol       Date:  2009-06-11       Impact factor: 3.715

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.